These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15546145)

  • 21. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.
    Yin Q; Flemington EK
    Virology; 2006 Mar; 346(2):385-93. PubMed ID: 16343579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast.
    Kapoor P; Shire K; Frappier L
    EMBO J; 2001 Jan; 20(1-2):222-30. PubMed ID: 11226172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication of Epstein-Barr viral DNA.
    Hammerschmidt W; Sugden B
    Cold Spring Harb Perspect Biol; 2013 Jan; 5(1):a013029. PubMed ID: 23284049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
    Perez EM; Foley J; Tison T; Silva R; Ogembo JG
    Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes.
    Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
    Biol Chem; 2000 Feb; 381(2):95-105. PubMed ID: 10746740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.
    Nasimuzzaman M; Kuroda M; Dohno S; Yamamoto T; Iwatsuki K; Matsuzaki S; Mohammad R; Kumita W; Mizuguchi H; Hayakawa T; Nakamura H; Taguchi T; Wakiguchi H; Imai S
    Mol Ther; 2005 Apr; 11(4):578-90. PubMed ID: 15771960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
    Lindner SE; Sugden B
    Plasmid; 2007 Jul; 58(1):1-12. PubMed ID: 17350094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus nuclear antigen-1-dependent and -independent oriP-binding cellular proteins.
    Kusano S; Tamada K; Senpuku H; Harada S; Ito S; Yanagi K
    Intervirology; 2001; 44(5):283-90. PubMed ID: 11684889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids.
    Kanda T; Kamiya M; Maruo S; Iwakiri D; Takada K
    J Cell Sci; 2007 May; 120(Pt 9):1529-39. PubMed ID: 17405814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells.
    Greijer AE; Ramayanti O; Verkuijlen SA; Novalić Z; Juwana H; Middeldorp JM
    J Virol Methods; 2017 Mar; 241():24-33. PubMed ID: 27993616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.